The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center. Presented today on the press program of the 2008 Chicago
Full Post: Combination of carboplatin and paclitaxel with bevacizumab and cetuximab proves safe for lung cancer treatment
According to scientists risk takers and drug abusers behave the way they do because their brains are less able to process dopamine.
The scientists from Vanderbilt University say that risk-takers and impulsive people, who make New Year’s resolutions face an uphill battle.
Such New Year pledges often include being more careful, spending more frugally and cutting back on dangerous behaviour such as drug use, but new research from the Vanderbilt team has found that these novelty seeking individuals will have to fight to keep to their commitments because of the way their brains process dopamine.
Their research has revealed that novelty seekers have less of a particular type of dopamine receptor, which may lead them to seek out novel and exciting experiences - such as spending lavishly, taking risks and endless partying.
The neurotransmitter dopamine is produced by a select group of cells in the brain and these dopamine-producing cells have receptors called autoreceptors that help limit dopamine release when these cells are stimulated.
Dr. David Zald, associate professor of psychology and lead author of the study, says they found that the density of these dopamine autoreceptors is inversely related to an individual’s interest in and desire for novel experiences - the fewer available dopamine autoreceptors an individual has, the less they are able to regulate how much dopamine is released when these cells are engaged.
Because of this, novelty and other potentially rewarding experiences that normally induce dopamine release will produce greater dopamine release in these individuals.
Dopamine is well-known as playing an important role in how we experience rewards from a variety of natural sources, including food and sex, as well as from drugs such as cocaine and amphetamine.
Previous research has shown that individuals differ in both their number of dopamine receptors and the amount of dopamine they produce, and that these differences may play a critical role in addiction and Dr. Zald and his colleagues set out to explore the connection between dopamine receptors and the novelty-seeking personality trait.
They say novelty-seeking personality traits are a major risk factor for the development of drug abuse and other unsafe behaviours and their research suggests that in high novelty-seeking individuals, the brain is less able to regulate dopamine, and this may lead these individuals to be particularly responsive to novel and rewarding situations that normally induce dopamine release.
Previous research in rodents showed that some respond differently to novel environments and those who explore novel environments more are also more likely to self-administer cocaine when given the chance.
Dopamine neurons fire at a higher rate in these novelty-responsive rodents, and the animals also have weak autoreceptor control of their dopamine neurons and the researchers suggest that the same relationships would be seen in humans.
The researchers used positron emission topography to view the levels of dopamine receptors in 34 healthy humans who had taken a questionnaire that measured the novelty-seeking personality trait.
The questionnaire measured things such as an individual’s preference for and response to novelty, decision-making speed, a person’s readiness to freely spend money, and the extent to which a person is spontaneous and unconstrained by rules and regulations - the higher the score, the more likely the person was to be a novelty seeker.
The researchers found that those that scored higher on the novelty-seeking scale had decreased dopamine autoreceptor availability compared to the subjects that scored lower.
The research was funded by the National Institute of Drug Abuse and is published in the December 31st, 2008, issue of the Journal of Neuroscience.
--------------------------------------------------------------------------------------------
Related Posts:
The University of Rochester Medical Center (URMC) is leading a multi-center clinical research study of a new experimental treatment for Tourette’s syndrome. The study will examine whether or not a drug that alters the chemical activity in the brain can alleviate the symptoms of the disease. Tourette’s syndrome (TS) is a neurological disorder characterized by
Full Post: New experimental treatment for Tourette’s syndrome
A large proteomics study on the brains of newborn mice provides more evidence that numbing drugs often used in obstetric or pediatric medicine can have profound and long-term negative effects, even after minimal exposure. This study, appearing in the December issue of Molecular and Cellular Proteomics , highlights the delicate state of the developing nervous
Full Post: Numbing drugs can have profound and long-term negative effects
Rewarding and stressful signals don’t seem to have much in common. But researchers studying diseases ranging from drug addiction to anxiety disorders are finding that the brain’s reward and stress signaling circuits are intertwined in complex ways. Vanderbilt University Medical Center investigators have now discovered a functional link between reward and stress. They found that
Full Post: Researchers find brain’s reward and stress signaling circuits are intertwined in complex ways
People with a stable psychosocial life situation often delay in seeking help for their alcohol problems - even though they are serious. This is revealed in a new thesis from the University of Gothenburg. Working actively to intervene at an early stage in order to prevent alcohol problems and to thereby promote public health is
Full Post: Socially stable individuals delay seeking help for alcohol problems
A Princeton University scientist will present new evidence demonstrating that sugar can be an addictive substance, wielding its power over the brains of lab animals in a manner similar to many drugs of abuse. Professor Bart Hoebel and his team in the Department of Psychology and the Princeton Neuroscience Institute have been studying signs of
Full Post: Sugar is addictive --------------------------------------------------------------------------------------------
